Current Issue

Jun 2024View Current Issue

Introduction: Infections in cirrhotic patients represent an important cause of decompensation, with an increased risk of sepsis and death and the most frequently incriminated infections are spontaneous bacterial peritonitis, urinary tract infections and pneumonia.

Materials and Methods: In a single – center retrospective cohort study, we analyzed data from 155 patients included on the waiting list for liver transplantation, such as biochemical parameters – serum C reactive protein and procalcitonin values, prognostic scores for....[more]

Impact of Psoas Muscle Wasting Among Cirrhotic Patients Awaiting Liver Transplantation: Predictor of Mortality and Transplant Select....
Corina Pietrareanu, Speranta Maria Iacob, Carmen Cristina Ester, Mihaela Corina Ghioca, Liliana Simona Gheorghe
ORIGINAL PAPER, Jun 2024
Article DOI: 10.21614/sgo-686
Read article

 

Introduction: In this study were included patients with liver cirrhosis waiting for liver transplantation. The study aims were to assess the prevalence and predictors of decreased muscle mass which is a frequent finding in liver cirrhosis associated with a poor prognosis.

Material and Method: The study included 133 patients with liver cirrhosis, who were splited into two groups, low and high, based on their psoas muscle index (PMI). The PMI was calculated using the area of the psoas muscle measured on CT or MRI images andmore]

Plateletcrit and Mean Platelet Volume in the Evaluation of Liver Cirrhosis and Nonalcoholic Fatty Liver Disease in Egyptian Patients
Abdel-Naser Abdel-Atty Gadallah, Elsayed Ibrahim Elshayeb, Belal Abd El-Mohsen Montaser, Ghada Ahmed Abdel-Fattah Shaheen, Ahmed Ezz El-Arab Abd El-Alim Mostafa
ORIGINAL PAPER, Jun 2024
Article DOI: 10.21614/sgo-643
Read article

Background: Non-alcoholic fatty liver disease (NAFLD) and cirrhosis represent significant global health concerns, often diagnosed through invasive methods like liver biopsy. Identifying non-invasive biomarkers for these conditions could greatly enhance early detection and management. Objective: To evaluate the relationship between Procalcitonin (PCT) and Mean Platelet Volume (MPV) levels and hepatic steatosis in patients with NAFLD and cirrhosis.

 

Methods: a case-control study included 133 participants divided into N....[more]

Predictors of Long-Term Clinical Response in Complex Perianal Fistulizing Crohn's Disease - A Retrospective Study
Ana Cristina Silva, Ezequiel Silva, Pedro Brandão, Mónica Sampaio, Andreia Teixeira, Paula Lago, Marisa Domingues Santos
ORIGINAL PAPER, Jun 2024
Article DOI: 10.21614/sgo-678
Read article

 

Background: Treatment of complex perianal fistula (cPF) in Crohn’s Disease (CD) constitutes a major challenge for gastroenterologists and surgeons. The aim of this study is to review the experience of a tertiary reference centre and identify prognostic factors related to non-response to treatment.

 

Methods: Retrospective cohort study of adult patients with CD operated on for cPF, in a

tertiary reference centre, from January 2015 to June 2023 and followed up until December 2023. Characteristics of ....[more]

Role of Indocyanine Green in Diagnostic Staging Laparoscopy in Intra-Abdominal Malignancy
Mohamed Hassan Sobeih Badreldeen, Ahmed Fahmy Omar, Tarek Osama Hegazy, M Emad Esmat, MM Essawy, Mohammed S Hedaya, Lamiaa Rafaat El sayed, Mahmoud Mohamed Rady, Mohamed Abdo
ORIGINAL PAPER, Jun 2024
Article DOI: 10.21614/sgo-677
Read article

Background: Patients with abdominal cancers may present with advanced disease either locally or metastatic and so, accurate staging help in selection of the appropriate treatment plan (curative or palliative). Up to 50% of patients diagnosed with colorectal cancers (CRC) and 40% of patients diagnosed with pancreatic cancers will have  metastatic hepatic lesions during the course of the disease, where 7% of patents with CRC and 14% of patients with advanced gastric cancers will develop peritoneal metastases. Despite advances in pre-operative imaging used for d....[more]

Search The Journal

Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Jun 2024

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/